Patent ID: 11897918
Assignee: SEQIRUS UK LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. A method for producing influenza virus particles or influenza virus proteins from suspension MDCK cells comprising:
growing or culturing the suspension MDCK cells for a duration of time, at least a portion of which is carried out in the presence of at least one chemical agent selected from the group consisting of fluvastatin, atorvastatin, cerivastatin, lovastatin, mevastatin, pravastatin or isomers thereof;
harvesting the influenza virus particles or influenza virus proteins from the suspension MDCK cells; and
formulating the influenza virus particles or influenza virus proteins into a pharmaceutical composition;
wherein the at least one chemical agent has a concentration of 0.001 μM to 5 μM in culture.